We tried Amazon’s new AI wearable Bee. It’s not for pro users yet, but more features are expected this year…
A new year is often meant to symbolize fresh starts, but for one of America’s most recognizable casual dining brands, 2024 delivered the opposite. Instead of renewal, the year was marked by financial troubles, bankruptcy, and a significant loss of its domestic and international footprints. Founded …
Ford Motor Company (F) wrapped up 2025 with impressive gains. The Detroit automaker saw its shares climb 33%, outpacing Tesla’s performance by a significant margin for the year. Market sentiment shifted dramatically for the maker of America’s bestselling vehicle, the F-Series pickup truck. …
The stock market and investment portfolios are continually evolving. With banks recommending the incorporation of cryptocurrencies in their investments and including artificial intelligence and energy growth stocks, another conversation has extended into the new year: Is energy the key to …
With AI igniting an investor frenzy, every month, more startups obtain unicorn status. Using data from Crunchbase and PitchBook, TechCrunch tracked down the VC-backed startups that became unicorns in 2025. While most are AI-related, a surprising number are focused in other industries like satellite space companies Loft Orbital and blockchain-based trading site Kalshi. This list will be updated…
OpenAI announced it has acquired a tiny startup called Torch for an undisclosed sum. An unnamed source told The Information that OpenAI paid $100 million worth of equity for the startup. Torch’s four-person team is joining OpenAI, both companies said. Torch was working on an app that combined all of a person’s medical information for…
Wall Street indexes gain with tech, Walmart
When it comes to your money, the chair of the Federal Reserve has more power than you might think. Credit cards? Check.Student loans? Check.Auto loans? Check. Then there’s the impact on mortgage rates, your stock portfolio, and regulation of the nation’s banking industry. Add the U.S…
Bank of America Global Research upped its rating on Regeneron Pharmaceuticals and its price target to $860 because it has a better view on Eylea HD, Dupixent is growing steadily, and there are several catalysts for 2026. Bank of America Global Research raised its rating on Regeneron …
After roughly 15 months of the Covid pandemic lockdowns, I sat with my laptop outside a Starbucks in West Palm Beach. It seemed like a little thing, but when I realized how long I had been surviving off of drive-thru and pickup, I started to cry…





